Drugs / Siroquine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03008148 | Oct 2018 → Apr 2025 | glioblastoma | Johnpro Biotech, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Siroquine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03008148 ↗ |
| Route | Oral | “Subjects will self-administer investigational product orally with water at approximately the same time in each day.” NCT03008148 ↗ |